Supplementary Figure 5 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells

Supplementary Figure 5 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells

<p>Supplementary Figure 5</p>

保存先:

書誌詳細
第一著者:	Francisco Exposito (16721403) (author)
その他の著者:	Miriam Redrado (16721406) (author), Maeva Houry (16721409) (author), Katherine Hastings (16721412) (author), Magdalena Molero-Abraham (16721415) (author), Teresa Lozano (16721418) (author), Jose Luis Solorzano (16721421) (author), Julian Sanz-Ortega (16721424) (author), Vera Adradas (16721427) (author), Ramon Amat (16721430) (author), Esther Redin (16721433) (author), Sergio Leon (16721436) (author), Naroa Legarra (16721439) (author), Javier Garcia (16721442) (author), Diego Serrano (16721445) (author), Karmele Valencia (14962695) (author), Camila Robles-Oteiza (16721448) (author), Giorgia Foggetti (15118568) (author), Nerea Otegui (16721451) (author), Enriqueta Felip (16721454) (author), Juan J. Lasarte (16721457) (author), Luis Paz-Ares (16721460) (author), Jon Zugazagoitia (16721463) (author), Katerina Politi (15313362) (author), Luis Montuenga (16721466) (author), Alfonso Calvo (16721469) (author)
出版事項:	2025
主題:	Cancer Cancer Biology Immuno-oncology Immunotherapy Combination immunotherapy Lung Cancer Oncogenes & Tumor Suppressors PD-1
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Supplementary Figure 1 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
著者:: Francisco Exposito (16721403)
出版事項: (2025)

Supplementary Figure 2 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
著者:: Francisco Exposito (16721403)
出版事項: (2025)

Supplementary Figure 3 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
著者:: Francisco Exposito (16721403)
出版事項: (2025)

Supplementary Figure 4 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
著者:: Francisco Exposito (16721403)
出版事項: (2025)

Processed single-cell RNA-seq dataset of cancer-associated fibroblasts in breast cancer patients receiving anti–PD-1 therapy
著者:: Thang Pham (19938126)
出版事項: (2025)

Supplementary Table 1 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1
著者:: Caroline Robert (15032672)
出版事項: (2025)

Supplementary Table 2 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1
著者:: Caroline Robert (15032672)
出版事項: (2025)

Supplementary Table 3 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1
著者:: Caroline Robert (15032672)
出版事項: (2025)

Supplementary Table 4 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1
著者:: Caroline Robert (15032672)
出版事項: (2025)

Data Sheet 3_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
著者:: Hailong Pang (12841991)
出版事項: (2025)

Data Sheet 2_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
著者:: Hailong Pang (12841991)
出版事項: (2025)

Data Sheet 1_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
著者:: Hailong Pang (12841991)
出版事項: (2025)

Supplementary Table S1 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
著者:: Hansol Lee (15054787)
出版事項: (2025)

Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
著者:: Hansol Lee (15054787)
出版事項: (2025)

Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
著者:: Hansol Lee (15054787)
出版事項: (2025)

Supplementary Table S4 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
著者:: Hansol Lee (15054787)
出版事項: (2025)

File_S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
著者:: Stéphane Fattori (15048281)
出版事項: (2025)

Table S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
著者:: Stéphane Fattori (15048281)
出版事項: (2025)

Table S2 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
著者:: Stéphane Fattori (15048281)
出版事項: (2025)

Table S3 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
著者:: Stéphane Fattori (15048281)
出版事項: (2025)

Table S4 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
著者:: Stéphane Fattori (15048281)
出版事項: (2025)

Table S5 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
著者:: Stéphane Fattori (15048281)
出版事項: (2025)

Table S6 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
著者:: Stéphane Fattori (15048281)
出版事項: (2025)

Table S7 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
著者:: Stéphane Fattori (15048281)
出版事項: (2025)

Table S8 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
著者:: Stéphane Fattori (15048281)
出版事項: (2025)

Table S2, S4, S5, S6 and S7 from Single-Cell Analysis Reveals a CD4<sup>+</sup> T-cell Cluster That Correlates with PD-1 Blockade Efficacy
著者:: Hiroshi Kagamu (14961732)
出版事項: (2025)

Supplementary Figure S1 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
著者:: Ulka N. Vaishampayan (15051039)
出版事項: (2025)

Supplementary Figure S2 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
著者:: Ulka N. Vaishampayan (15051039)
出版事項: (2025)

Supplementary Figure S3 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
著者:: Ulka N. Vaishampayan (15051039)
出版事項: (2025)

Supplementary Table S2 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
著者:: Ulka N. Vaishampayan (15051039)
出版事項: (2025)

Supplementary File 1 from Cetuximab Responses in Patients with HNSCC Correlate to Clonal Expansion Feature of Peripheral and Tumor-Infiltrating T Cells with Top T-Cell Receptor Clonotypes
著者:: Huaibin Ge (15047462)
出版事項: (2025)

Datasets for bibliometric analysis of regulatory T cells in gastric cancer (2005-2025)
著者:: Houshu Tu (22026668)
出版事項: (2025)

TS1-9 from Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
著者:: Lavanya Sivapalan (15314248)
出版事項: (2025)

Supplementary Figure S1 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
著者:: Rohit Thummalapalli (17314483)
出版事項: (2025)

Supplementary Figure S10 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
著者:: Rohit Thummalapalli (17314483)
出版事項: (2025)

Supplementary Figure S11 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
著者:: Rohit Thummalapalli (17314483)
出版事項: (2025)

Supplementary Figure S12 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
著者:: Rohit Thummalapalli (17314483)
出版事項: (2025)

Supplementary Figure S13 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
著者:: Rohit Thummalapalli (17314483)
出版事項: (2025)

Supplementary Figure S14 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
著者:: Rohit Thummalapalli (17314483)
出版事項: (2025)

Supplementary Figure S15 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
著者:: Rohit Thummalapalli (17314483)
出版事項: (2025)

Cannot write session to /tmp/vufind_sessions/sess_ghipm71hq4d3gvtuidshcvil10